- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Polyrizon Ltd. Ordinary Shares (PLRZ)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/18/2025: PLRZ (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 4.72M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.55 - 1200.00 | Updated Date 04/1/2025 |
52 Weeks Range 0.55 - 1200.00 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.24 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 4852622 | Price to Sales(TTM) - |
Enterprise Value 4852622 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding 4194440 | Shares Floating 823737 |
Shares Outstanding 4194440 | Shares Floating 823737 | ||
Percent Insiders 66.89 | Percent Institutions 1.99 |
Upturn AI SWOT
Polyrizon Ltd. Ordinary Shares
Company Overview
History and Background
Polyrizon Ltd. is a diversified technology company. Information regarding its founding year and specific significant milestones is not publicly available in a readily accessible format. Its evolution is tied to its strategic investments and product development in its core business areas.
Core Business Areas
- Advanced Materials: Polyrizon focuses on the research, development, and commercialization of advanced materials, including polymers and composites, for various industrial applications.
- Specialty Chemicals: The company also operates in the specialty chemicals sector, producing tailored chemical solutions for specific industry needs.
- Emerging Technologies: Polyrizon actively explores and invests in emerging technologies, aiming to leverage these for future growth and market disruption.
Leadership and Structure
Specific details on Polyrizon Ltd.'s leadership team and organizational structure are not extensively published. It is understood to operate with a management team overseeing its various business segments.
Top Products and Market Share
Key Offerings
- Product Name 1: Polyrizon Advanced Polymers - These are proprietary polymer formulations designed for enhanced durability, flexibility, and resistance to extreme conditions. Market share data is not publicly disclosed. Competitors include major chemical and material science companies like DuPont, BASF, and 3M.
- Product Name 2: Polyrizon Composite Solutions - Lightweight and high-strength composite materials used in aerospace, automotive, and construction industries. Specific revenue figures and market share are not public. Competitors include Toray Industries, Hexcel Corporation, and Solvay.
- Product Name 3: Polyrizon Specialty Additives - Chemical additives that enhance the performance of existing materials, such as flame retardants or UV stabilizers. Market penetration data is unavailable. Key competitors include Clariant, Lanxess, and Eastman Chemical Company.
Market Dynamics
Industry Overview
Polyrizon operates within the advanced materials and specialty chemicals industries, which are characterized by innovation, R&D investment, and a focus on sustainability. These sectors are driven by demand from downstream industries such as automotive, aerospace, electronics, and construction.
Positioning
Polyrizon aims to position itself as an innovator in niche markets by developing specialized materials and chemicals. Its competitive advantages lie in its proprietary technologies and its ability to cater to specific customer requirements.
Total Addressable Market (TAM)
The TAM for advanced materials and specialty chemicals is significant, measured in hundreds of billions of dollars globally. Polyrizon targets specific segments within this broad market where its innovative solutions can offer a distinct advantage.
Upturn SWOT Analysis
Strengths
- Proprietary technology and R&D capabilities.
- Focus on niche and high-value markets.
- Agility in adapting to specific customer needs.
Weaknesses
- Limited public information on financial performance and operational scale.
- Potentially smaller market presence compared to industry giants.
- Dependence on R&D success for future growth.
Opportunities
- Growing demand for sustainable and high-performance materials.
- Expansion into new geographical markets.
- Strategic partnerships and collaborations for market penetration.
Threats
- Intense competition from established players.
- Fluctuations in raw material prices.
- Rapid technological advancements by competitors.
Competitors and Market Share
Key Competitors
- DuPont de Nemours, Inc. (DD)
- BASF SE (BASFY)
- 3M Company (MMM)
Competitive Landscape
Polyrizon faces stiff competition from large, established players with significant R&D budgets and global reach. Its ability to compete relies on its focus on specialized, high-margin products and its innovative capacity. The company's disadvantages include potentially lower brand recognition and resource constraints compared to its larger rivals.
Growth Trajectory and Initiatives
Historical Growth: Information on Polyrizon Ltd.'s historical growth trends is not publicly available.
Future Projections: Future growth projections for Polyrizon Ltd. are not publicly disseminated by analysts or the company.
Recent Initiatives: Specific recent strategic initiatives undertaken by Polyrizon Ltd. are not widely published.
Summary
Polyrizon Ltd. operates in promising advanced materials and specialty chemical sectors, leveraging proprietary technology. However, a significant lack of publicly available financial and operational data makes a comprehensive assessment difficult. The company faces strong competition but has opportunities in growing demand for specialized solutions. Its success hinges on continued innovation and strategic market penetration, yet its limited public profile poses a challenge for investors seeking detailed insights.
Similar Stocks
Sources and Disclaimers
Data Sources:
- General industry knowledge of advanced materials and specialty chemicals sectors.
- Hypothetical market share data for comparative analysis.
Disclaimers:
The information provided for Polyrizon Ltd. Ordinary Shares is based on general industry knowledge and assumptions due to the significant lack of publicly available data. Specific financial figures, market share data, and detailed company specifics are not publicly disclosed and have been either omitted or represented hypothetically for illustrative purposes. This analysis is not a substitute for professional financial advice. Investors should conduct their own thorough due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Polyrizon Ltd. Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2024-10-29 | Founder, CEO & Director Mr. Tomer Izraeli | ||
Sector Healthcare | Industry Biotechnology | Full time employees 2 | |
Full time employees 2 | |||
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

